Search results for "Radiation"

showing 10 items of 5298 documents

Halloysite/Keratin Nanocomposite for Human Hair Photoprotection Coating

2020

We propose a novel keratin treatment of human hair by its aqueous mixtures with natural halloysite clay nanotubes. The loaded clay nanotubes together with free keratin produce micrometer-thick protective coating on hair. First, colloidal and structural properties of halloysite/keratin dispersions and the nanotube loaded with this protein were investigated. Above the keratin isoelectric point (pH = 4), the protein adsorption into the positive halloysite lumen is favored because of the electrostatic attractions. The ζ-potential magnitude of these core-shell particles increased from -35 (in pristine form) to -43 mV allowing for an enhanced colloidal stability (15 h at pH = 6). This keratin-cla…

AdultNanotubeMaterials scienceUltraviolet RaysRadiation-Protective Agentshalloysite nanotubes02 engineering and technologyengineering.material010402 general chemistry01 natural sciencesHalloysiteNanocompositesColloidCoatingKeratinHumansGeneral Materials SciencecompositekeratinSettore CHIM/02 - Chimica Fisicachemistry.chemical_classificationNanotubesNanocompositeintegumentary system021001 nanoscience & nanotechnologyhair treatment0104 chemical sciencesIsoelectric pointchemistryChemical engineeringUV-protective coatingengineeringClayKeratinsFemale0210 nano-technologyResearch ArticleHairProtein adsorptionACS Applied Materials & Interfaces
researchProduct

Dose-dependent expression of CLIP2 in post-Chernobyl papillary thyroid carcinomas

2015

Summary This study showed a clear dose-response relationship for the CLIP2 radiation marker in post-Chernobyl papillary thyroid carcinoma cohorts for young patients and hints to different molecular mechanisms in tumors induced at low doses compared to moderate/high doses.

AdultOncologyendocrine systemCancer Researchmedicine.medical_specialtyPathologyNeoplasms Radiation-InducedAdolescentendocrine system diseasesOriginal ManuscriptCohort StudiesIodine RadioisotopesThyroid carcinomaYoung Adult03 medical and health sciences0302 clinical medicineInternal medicineBiomarkers TumormedicineCarcinomaHumansThyroid NeoplasmsTypingYoung adultChildThyroid cancer030304 developmental biology0303 health sciencesbusiness.industryCarcinomaThyroidDose-Response Relationship RadiationGeneral Medicinemedicine.diseaseCarcinoma Papillaryhumanities3. Good healthLogistic Modelsmedicine.anatomical_structureChernobyl Nuclear AccidentThyroid Cancer PapillaryChild Preschool030220 oncology & carcinogenesisCohortbusinessMicrotubule-Associated ProteinsCohort studyCarcinogenesis
researchProduct

Long‐term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42‐month analysis of the phase II randomized, double‐blind…

2019

Background: Basal cell carcinomas (BCCs) exhibit aberrant activation of the hedgehog pathway. Sonidegib is a hedgehog pathway inhibitor approved for the treatment of locally advanced BCC (laBCC) and metastatic BCC (mBCC) based on primary results of the BOLT study [Basal Cell Carcinoma Outcomes with LDE225 (sonidegib) Treatment]. Objectives: This is the final 42-month analysis of the BOLT study, evaluating the efficacy and safety of sonidegib. Methods: Adults with no prior hedgehog pathway inhibitor therapy were randomized in a 1 : 2 ratio to sonidegib 200 mg or 800 mg once daily. Treatment continued for up to 42 months or until disease progression, unacceptable toxicity, death, study termin…

AdultOncologymedicine.medical_specialtySkin NeoplasmsPyridinesmedicine.medical_treatmentAntineoplastic AgentsDermatologySonidegiblaw.invention030207 dermatology & venereal diseases03 medical and health scienceschemistry.chemical_compound0302 clinical medicineRandomized controlled triallawInternal medicinemedicineCarcinomaHumansHedgehog ProteinsBasal cell carcinomaAdverse effectbusiness.industryBiphenyl Compoundsmedicine.diseaseRadiation therapyClinical trialBiphenyl compoundchemistryCarcinoma Basal CellbusinessBritish Journal of Dermatology
researchProduct

Tumor oxygenation: a new predictive parameter in locally advanced cancer of the uterine cervix.

1993

Abstract Experimental evidence suggests that hypoxia may increase the malignant potential and reduce the sensitivity toward nonsurgical treatment modalities in solid rodent tumors. However, the importance of tumor hypoxia in human malignancies is still uncertain. We have developed a clinically applicable standardized procedure for the determination of intratumoral p O 2 in advanced cervical cancers by use of a computerized polarographic needle electrode histograph. To evaluate the significance of tumor oxygenation as a new oncologic parameter we initiated an open prospective clinical trial at the University of Mainz Medical Center in June 1989. Until October 1992 50 patients with advanced c…

AdultPathologymedicine.medical_specialtymedicine.medical_treatmentBrachytherapyUrologyUterine Cervical NeoplasmsMedicineHumansProspective StudiesElectrodesAgedChemotherapyTumor hypoxiabusiness.industryProportional hazards modelObstetrics and GynecologyOxygenationTumor OxygenationHypoxia (medical)Middle AgedPrognosisCombined Modality TherapyCell HypoxiaRadiation therapyClinical trialOxygenTreatment OutcomeOncologyRegression AnalysisFemalemedicine.symptomRadioisotope TeletherapybusinessGynecologic oncology
researchProduct

Colon pouch (Mainz pouch III) for continent urinary diversion after pelvic irradiation

2000

Abstract Objectives. Urinary diversion after previous pelvic irradiation is challenging. The use of irradiated bowel in particular is associated with an increased rate of early and late complications. We therefore performed continent cutaneous urinary diversion using exclusively nonirradiated bowel segments in this group of patients. Methods. A continent colon pouch for urinary diversion was performed in 44 female patients after pelvic irradiation. The indications were irreparable vesical fistula in 20, local recurrence of gynecologic tumors in 22, and radical cystectomy for bladder cancer in 2 patients. Depending on the length of the nonirradiated bowel segment, a transverse-ascending colo…

AdultReoperationmedicine.medical_specialtyColonUrologymedicine.medical_treatmentUrologyUterine Cervical NeoplasmsUrinary DiversionAnastomosisCystectomyCloacaColon surgerymedicineHumansRadiation InjuriesAgedUpper urinary tractUrinary bladderVesicovaginal FistulaUrinary Bladder Fistulabusiness.industryAnastomosis SurgicalUrinary Reservoirs ContinentUrinary diversionMiddle AgedSurgeryTreatment Outcomemedicine.anatomical_structureFemaleNeoplasm Recurrence LocalPouchbusinessContinent Urinary DiversionFollow-Up StudiesUreteral ObstructionUrology
researchProduct

Long-term outcome of treatment with dacarbazine, cisplatin, interferon-α and intravenous high dose interleukin-2 in poor risk melanoma patients

1998

Melanoma patients with very advanced disease are usually excluded from chemoimmunotherapy trials; however, the efficacy of intensive treatment regimens needs to be established for this patient population. This study aimed to evaluate the response rate and survival achieved with chemoimmunotherapy in very advanced melanoma patients. Forty-two patients received dacarbazine (250 mg/m2, days 1-3), cisplatin (30mg/m2, days 1-3), interferon-alpha (10 Mio IU/m2 subcutaneously, days 1-5) and intravenous interleukin-2 (18 Mio IU/m2 over 6 h, 12 h then 24 h, followed by 13.5 MioIU/m2 in 72 h). In cases of brain metastases (n = 12) radiation therapy was added. Ten patients (24%) achieved a partial res…

AdultRiskInterleukin 2Cancer Researchmedicine.medical_specialtySkin NeoplasmsTime Factorsmedicine.medical_treatmentDacarbazineDermatologyGastroenterologyStable DiseaseChemoimmunotherapyInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansNeoplasm MetastasisMelanomaAgedResponse rate (survey)CisplatinL-Lactate DehydrogenaseBrain Neoplasmsbusiness.industryMelanomaInterferon-alphaMiddle AgedPrognosismedicine.diseaseDacarbazineSurvival RateRadiation therapyTreatment OutcomeOncologyInterleukin-2Cisplatinbusinessmedicine.drugMelanoma Research
researchProduct

Does Conservative Surgery for Breast Carcinoma Still Require Axillary Lymph Node Evaluation? A Retrospective Analysis of 1156 Consecutive Women With …

2016

Abstract Background The role of axillary surgery for early breast carcinoma treated with conservative surgery and radiotherapy is currently the subject of considerable investigation. Recent studies have supported the noninferiority of avoiding axillary surgery in terms of overall survival when sentinel lymph node biopsy (SLNB) presents ≤ 2 positive lymph nodes, thus sparing the patients from complications. There are some ongoing studies investigating the possibility of omitting SLNB. Axillary study seems to be sufficiently replaced by SLNB for staging the disease. Axillary surgery maintains a therapeutic role in the presence of > 2 metastatic lymph nodes at SLNB. Patients and Methods We per…

AdultT1 tumorsCancer Researchmedicine.medical_specialtymedicine.medical_treatmentSentinel lymph nodePopulationBreast Neoplasms030230 surgeryConservative Treatment03 medical and health sciences0302 clinical medicineBreast cancerAxillary lymph node dissectionmedicineHumansMore than two metastatic axillary lymph nodeeducationLymph nodeAgedNeoplasm StagingRetrospective StudiesAged 80 and overeducation.field_of_studybusiness.industrySentinel Lymph Node BiopsyAxillary Lymph Node DissectionAxillary lymph node dissection; More than two metastatic axillary lymph nodes; Not axillary surgery staging; Sentinel lymph node biopsy; T1 tumorsMiddle Agedmedicine.diseaseSurgeryRadiation therapymedicine.anatomical_structureOncology030220 oncology & carcinogenesisLymphatic MetastasisAxillaLymph Node ExcisionNot axillary surgery stagingFemaleRadiotherapy AdjuvantLymphSentinel Lymph NodeBreast carcinomabusinessClinical breast cancer
researchProduct

Laparoscopic Radical Hysterectomy After Concomitant Chemoradiation in Locally Advanced Cervical Cancer: A Prospective Phase II Study

2015

Abstract Study Objective To assess the feasibility of total robotic radical surgery (TRRS) in patients with locally advanced cervical cancer (LACC) who receive chemoradiation therapy (CT/RT). Design A prospective (preplanned) study of a nonrandomized controlled trial (Canadian Task Force classification level 2). Setting Catholic University of the Sacred Hearth, Rome, Italy. Patients Between September 2013 and January 2016, a total of 40 patients with LACC (Federation Internationale de Gynecologie et d'Obstetrique stage IB2–III) were enrolled in the study. Interventions Robotic radical hysterectomy (RRH) plus pelvic and/or aortic lymphadenectomy was attempted within 6 weeks after CT/RT. The …

AdultUterine Cervical Neoplasmmedicine.medical_specialtymedicine.medical_treatmentUterine Cervical NeoplasmsHysterectomyPostoperative ComplicationsmedicineRadical hysterectomyHumansProspective StudiesCervical cancer; Laparoscopy; Neoadiuvant chemoradiation; Radical hysterectomy; Adult; Aged; Carcinoma; Squamous Cell; Chemoradiotherapy; Adjuvant; Cisplatin; Feasibility Studies; Female; Humans; Italy; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence; Local; Postoperative Complications; Prospective Studies; Uterine Cervical Neoplasms; Hysterectomy; Laparoscopy; Lymph Node ExcisionRadical surgeryRadical HysterectomyProspective cohort studyNeoadjuvant therapyAgedCervical cancerHysterectomybusiness.industryMedicine (all)Obstetrics and GynecologyLaparoscopic Radical HysterectomyPerioperativeChemoradiotherapy AdjuvantMiddle Agedmedicine.diseaseNeoadjuvant TherapySurgeryFeasibility StudieProspective StudieSettore MED/40 - GINECOLOGIA E OSTETRICIAItalyCervical cancerNeoadiuvant chemoradiationCarcinoma Squamous CellFeasibility StudiesLymph Node ExcisionLymphadenectomyFemaleLaparoscopyPostoperative ComplicationCisplatinNeoplasm Recurrence LocalbusinessHuman
researchProduct

External validation of a prognostic model estimating the survival of patients with recurrent high-grade gliomas after reirradiation

2015

PURPOSE: We aimed to validate a controversial prognostic model for the survival of relapsed malignant glioma patients after reirradiation with an independent, multicentric patient cohort.METHODS AND MATERIALS: A total of 165 malignant glioma patients underwent reirradiation at 4 different institutions between 1994 and 2012. Twenty-two patients had a good (score 1), 44 had a moderate (score 2), and 99 had a poor prognosis (score 3 or 4). Four statistical methods were used to validate the prognostic model: First, we compared survival according to prognostic group in the construction and the validation cohort by visual comparison of the respective Kaplan-Meier plots. Second, discrimination was…

Adultmedicine.medical_specialtyAdolescentKaplan-Meier Estimate030218 nuclear medicine & medical imagingRe-IrradiationCohort Studies03 medical and health sciencesYoung Adult0302 clinical medicineTheoreticalModelsGliomamedicineHumansRadiology Nuclear Medicine and imagingTime pointChildSurvival rateSurvival analysisAgedKaplan-Meier Estimatebusiness.industryBrain NeoplasmsHazard ratioGliomaModels TheoreticalMiddle Agedmedicine.diseasePrognosisSurgerySurvival RateOncology030220 oncology & carcinogenesisCohortCalibrationRadiologybusinessCohort studyPractical radiation oncology
researchProduct

Successful treatment of a young patient with locally advanced clear cell adenocarcinoma of the uterine cervix undergoing chemoradiation followed by r…

2014

Clear cell adenocarcinoma (CCAC) of the uterine cervix is a rare variant of cervical adenocarcinoma accounting for approximately 4-9% of this disease. Given the rarity of this pathological entity, the optimal treatment management is far from being defined. Earlier evidence suggested that the prognosis of patients bearing cervical CCAC is worse than with other histotypes, thus making the investigation of multimodal treatment strategies clinically worthwhile. Herein, we report the first case of locally advanced, large size cervical CCAC in a young woman who was triaged to concomitant chemoradiotherapy followed by radical surgery and experienced a pathologically assessed optimal response to th…

Adultmedicine.medical_specialtyAdvanced clear cell adenocarcinomaUterine Cervical NeoplasmRadical surgeryUterine Cervical NeoplasmsDisease-Free SurvivalObstetrics and gynaecologyadenocarcinoma uterine cervixUterine cervixmedicineHumansCombined Modality TherapyClear-cell adenocarcinomaRadical surgeryPathologicalSettore MED/08 - ANATOMIA PATOLOGICAbusiness.industryObstetrics and GynecologyMultimodal therapyChemoradiotherapy Adjuvantmedicine.diseaseMultimodal approachCombined Modality TherapyImmunohistochemistryMagnetic Resonance ImagingSurgeryChemoradiationReproductive MedicineAdenocarcinomaFemalebusinessChemoradiotherapyAdenocarcinoma Clear CellHuman
researchProduct